Low-dose Recombinant Human IL-2 for the Treatment of Rheumatoid Arthritis
Clinical trial NCT02467504 · COMPLETED
Trial details
- NCT number
- NCT02467504
- Sponsor
- Peking University People's Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2017-01-15
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.